Specific association of thiamine-coated gadolinium nanoparticles with human breast cancer cells expressing thiamine transporters

Bioconjugate Chemistry

Volumn 14, Issue 2, 2003, Pages 404-411

  Oyewumi, Moses O ^a   Liu, Shuqian ^b   Moscow, Jeffrey A ^b   Mumper, Russell J ^a,c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELLS; DISEASES; GADOLINIUM; GEL PERMEATION CHROMATOGRAPHY; LIGANDS; MICROEMULSIONS; POLYETHYLENE GLYCOLS; TUMORS;

BREAST CANCER CELLS; CELL ASSOCIATIONS; GADOLINIA; GADOLINIUM NANOPARTICLES; HUMAN BREAST CANCER CELLS; MICROEMULSION TEMPLATE; OIL-IN-WATER MICROEMULSIONS; SOLID NANOPARTICLES; SYNTHESISED; TUMOR-SPECIFIC LIGANDS;

NANOPARTICLES;

GADOLINIUM; LIGAND; NANOPARTICLE; THIAMINE DERIVATIVE;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; INCUBATION TIME; LIGAND BINDING; MICROEMULSION; NEUTRON CAPTURE THERAPY; SYNTHESIS; TEMPERATURE;

VECTORS;

EID: 0037344134     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc0340013     Document Type: Article

References (34)

1. Allen, B. J., McGregor, B. J., and Martin, R. F. (1989) Neutron capture therapy with gadolinium-157. Stahlenther Onkol. 165, 156-158.
2. Allen, T. M., Brandeis, E., Hansen, C. B., Kao, G. Y., and Zaplipsky, S. (1995) A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells. Biochim. Biophys. Acta 1237, 99-108.
3. Atkinson, S. F., Bettinger, T., Seymour, L. W., Behr, J., and Ward, C. (2001) Conjugation of folate via gelonin carbohydrate residues retains ribosomal-inactivating properties of the toxin and permits targeting to folate receptor positive cells. J. Biol. Chem. 276, 27930-27935.
4. Boros, L. G., Puigjaner, J., Cascante, M., Lee, W. N. P., Brandes, J. L., Bassilian, S., Yusurf, F. I., Williams, R. D., Muscarella, P., Melvin, W. S., and Schirmer, W. J. (1997) Oxythiamine and dehydroepiandrosterone inhibit the non-oxidative synthesis of ribose and cancer cell proliferation. Cancer Res. 57, 4242-4248.
5. Cascante, M., Centelles, J. J. Veech, R. L., Lee, W. N., and Boros, L. G. (2000) Role of thiamine (vitamin B-1) and transketolase in tumor cell proliferation. Nutr. Cancer 2, 150-154.
6. Cho, C. S., Cho, K. Y., Park, I. K., Kim, S. H., Sasagawa, T., Uchiyama, M., and Akaike, T. (2001) Receptor-mediated delivery of trans-retinoic acid to hepatocyte using poly (Llactic acid) nanoparticles coated with galactose-carrying polystyrene. J. Controlled Release 77, 7-15.
7. Comin-Aduix, B. Boren, J. Martonez, S. Moro, C., Centelles. J. J. Trebukhina, R., Petushok, N., Lee, W. P., Boros, L. G., and Cascante, M. (2001) The effect of thiamine supplementation on tumour proliferation. A metabolic control analysis study. Eur. J. Biochem. 268, 4177-4182.
8. Desai, M. P., Labhasetwar, V., Amidon, G. L., and Levy, R. J. (1996) Gastrointestinal uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm. Res. 14, 1568-1573.
9. Dixon, K. H., Trepel, J. B., Eng, S. C., and Cowan, K. H. (1991) Folate transport and the modulation of antifolate sensitivity in a methotrexate-resistant human breast cancer cell line. Cancer Commun. 3, 357-365.
10. Dixon, K. H., Lanpher, B. C., Chiu, J., Kelley, K., and Cowan, K. H. (1994) A novel cDNA restores reduced folate carrier activity and methotrexate sensitivity to transport deficient cells. J. Biol. Chem. 269, 17-20.
11. Goren, D., Horowitz, A. T., Tzemach, D., Tarshish, M. M., Zalipsky, S., and Gabizon, A. (2000) Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump. Clin. Cancer Res. 6, 1949-1957.
12. Jayamani, M., and Low, P. S. (1992) An efficient method for conjugation of thiamine to proteins. Biorg. Med. Chem. Lett. 2, 1007-1012.
13. Jain, R. K. (1997) Delivery of molecular and cellular medicine to solid tumors. Adv. Drug Deliv. Rev. 26, 71-90.
14. Kreuter, J. (1995) Nanoparticles as adjuvants for vaccines. Pharma. Biotechnol. 6, 463-472.
15. 2] glucose. Am. J. Physiol. 274, E843-E851.
16. Lee, R. J., and Low P. S. (1995). Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in-vitro. Biochim. Biophys. Acta 1233, 134-144.
17. Liu, S., Huang, H. Lu, X., Golinski, M., Comesse, S., Watt, D., Grossman, R., and Moscow, J. (2003). Down-regulation of thiamine transporter THTR2 gene expression in breast cancer and its association with resistance to apoptosis. Mol. Cancer Res., submitted.
18. Lo, P., Wang, F. (2002) Identification of transcriptional start sites and splicing of mouse thiamine transporter gene THTR-1 (Slc19a2). Biochim. Biophys. Acta 1576, 209-213.
19. Moscow, J. A., Gong, M., He, R., Sgagias, M. K., Dixion, K. H., Anzick, S. L., Meltzer, P. S., and Cowan, K. H. (1995) Isolation of gene encoding a human reduced folate carrier (RFC1) and analysis of its expression in transport-deficient, methotrexate-resistant human breast cancer cells. Cancer Res. 55, 3790-3794.
20. Moscow, J. A. Connolly, T., Myers, T., Paull, K., Cheng, C. C., and Cowan, K. H. (1997) Reduced folate carrier gene expression in transfected and nonselected cell lines. Int. J. Cancer. 72, 184-190.
21. Oyewumi, M. O., and Mumper, R. J. (2002a) Gadolinium-loaded nanoparticles engineered from microemulsions templates. Drug Dev. Ind. Pharm. 28, 317-328.
22. Oyewumi, M. O., and Mumper, R. J. (2002b) Engineering tumor-targeted gadolinium hexanedione nanoparticles for potential application in neutron capture therapy. Bioconjugate Chem. 13, 1328-1335.
23. Rajgoal, A., Edmondson, A., Goldman, D. I., and Zhao, R. (2001) SLC19A3 encodes a second thiamine transporter THTR2. Biochim. Biophys. Acta 1537, 175-178.
24. Russell-Jones, G. L., Arthur, L., and Walker, H. (1999). Vitamin B12-medaited transport of nanoparticles across Caco-2 cells. Int. J. Pharm. 179, 247-255.
25. Said, H. S., Orbitz, A., Kumar, C. K., Chatterjee, N., Dudeja, P. K., and Rubin, S. (1999) Transport of thiamine in human intestine: mechanism and regulation in intestinal epithelial cell model caco-2. Am. J. Physiol. 277, C645-C651.
26. Said, H. M., Orbitz, A., Subramanian, V. S., Neufeld, E. J., Moyer, M. P., and Dudeja, P. K. (2001) Mechanism of thiamine uptake by human colonocytes: studies with cultured colonic epithelial cell line NCM 460. Am. J. Physiol. Gastrointest. Liver Physiol. 284, G144-G150.
27. Seligmann, H. M., Levi, R. Konijn, A. M., and Prokocimer, M. (2001) Thiamine deficiency in patients with B-chronic lymphocytic leukaemia: a pilot study. Postgrad. Med. J. 77, 582-585.
28. Shih, J., and Brugger, R. M. (1992) Gadolinium as a neutron capture agent. Med. Phys. 3, 733-744.
29. Shikata, F., Tokumitsu, H., Ichikawa, H., and Fukumori, Y. (2002). In-vitro-cellular accumulation of gadolinium incorporated into chitosan nanoparticles designed for neutroncapture therapy of cancer. Eur. J. Pharm. Biopharm. 53, 57-63.
30. Singleton, C. K., and Martin, P. R. (2001) Molecular mechanisms of thiamine utilization. Curr. Mol. Med. 2, 197-207.
31. Vyas, S. P., Singh, A., and Sihorkar, V. (2001) Ligand-receptor mediated drug delivery: an emerging paradigm in cellular drug targeting. Crit. Rev. Ther. Drug Carrier Syst. 18, 1-76.
32. Wang, S., and Low, P. S. (1998) Folate-mediated targeting of antineoplastic drugs, imaging agents and nucleic acids to cancer cells. J. Controlled Release 53, 39-48.
33. Weng, G., Bhalla, U. S., and Iyenyar, R. (1999) Complexity in biological signaling systems. Science 284, 92-96.
34. Zhao, R., Gao, F., and Goldman, D. (2002) Reduced folate carrier transports thiamine monophospate: an alternative route for thiamine delivery into mammalian cells. Am. J. Physiol. Cell Physiol. 282, C1512-C1517.